nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.86	1	CbGbCtD
Fluorescein—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0349	0.358	CbGpPWpGaD
Fluorescein—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0162	0.167	CbGpPWpGaD
Fluorescein—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00334	0.0777	CcSEcCtD
Fluorescein—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00325	0.0334	CbGpPWpGaD
Fluorescein—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00302	0.0311	CbGpPWpGaD
Fluorescein—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00233	0.0543	CcSEcCtD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00213	0.0219	CbGpPWpGaD
Fluorescein—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.00209	0.0486	CcSEcCtD
Fluorescein—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00203	0.0473	CcSEcCtD
Fluorescein—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00201	0.0469	CcSEcCtD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00195	0.02	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00195	0.02	CbGpPWpGaD
Fluorescein—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0016	0.0372	CcSEcCtD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00148	0.0152	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00148	0.0152	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00137	0.0141	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00137	0.0141	CbGpPWpGaD
Fluorescein—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0312	CcSEcCtD
Fluorescein—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00131	0.0305	CcSEcCtD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00123	0.0126	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00122	0.0125	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00122	0.0125	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00116	0.012	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00116	0.012	CbGpPWpGaD
Fluorescein—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0266	CcSEcCtD
Fluorescein—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0261	CcSEcCtD
Fluorescein—CYP1A1—Biological oxidations—SLC26A1—nephrolithiasis	0.00109	0.0112	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00108	0.0111	CbGpPWpGaD
Fluorescein—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00107	0.025	CcSEcCtD
Fluorescein—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0247	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00104	0.0107	CbGpPWpGaD
Fluorescein—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00103	0.024	CcSEcCtD
Fluorescein—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00103	0.0239	CcSEcCtD
Fluorescein—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00101	0.0234	CcSEcCtD
Fluorescein—Cough—Hydrochlorothiazide—nephrolithiasis	0.000999	0.0233	CcSEcCtD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000991	0.0102	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000991	0.0102	CbGpPWpGaD
Fluorescein—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000974	0.0227	CcSEcCtD
Fluorescein—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000963	0.0224	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000949	0.00975	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000949	0.00975	CbGpPWpGaD
Fluorescein—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000934	0.0217	CcSEcCtD
Fluorescein—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000934	0.0217	CcSEcCtD
Fluorescein—Shock—Hydrochlorothiazide—nephrolithiasis	0.000919	0.0214	CcSEcCtD
Fluorescein—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000912	0.0212	CcSEcCtD
Fluorescein—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000903	0.021	CcSEcCtD
Fluorescein—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000873	0.0203	CcSEcCtD
Fluorescein—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000839	0.0195	CcSEcCtD
Fluorescein—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000833	0.0194	CcSEcCtD
Fluorescein—Pain—Hydrochlorothiazide—nephrolithiasis	0.000799	0.0186	CcSEcCtD
Fluorescein—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00077	0.0179	CcSEcCtD
Fluorescein—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000764	0.0178	CcSEcCtD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000751	0.00771	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000751	0.00771	CbGpPWpGaD
Fluorescein—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000742	0.0173	CcSEcCtD
Fluorescein—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000738	0.0172	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000719	0.00739	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000719	0.00739	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000698	0.00717	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000698	0.00717	CbGpPWpGaD
Fluorescein—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000688	0.016	CcSEcCtD
Fluorescein—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00067	0.0156	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000669	0.00687	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000669	0.00687	CbGpPWpGaD
Fluorescein—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000661	0.0154	CcSEcCtD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000623	0.00639	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000623	0.00639	CbGpPWpGaD
Fluorescein—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000618	0.0144	CcSEcCtD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000596	0.00612	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000596	0.00612	CbGpPWpGaD
Fluorescein—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000594	0.0138	CcSEcCtD
Fluorescein—Rash—Hydrochlorothiazide—nephrolithiasis	0.000589	0.0137	CcSEcCtD
Fluorescein—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000588	0.0137	CcSEcCtD
Fluorescein—Headache—Hydrochlorothiazide—nephrolithiasis	0.000585	0.0136	CcSEcCtD
Fluorescein—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000555	0.0129	CcSEcCtD
Fluorescein—ABCB11—Metabolism—GRHPR—nephrolithiasis	0.00055	0.00565	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000498	0.00511	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—AGXT—nephrolithiasis	0.00049	0.00503	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000476	0.00489	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—APRT—nephrolithiasis	0.000417	0.00428	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—SLC26A1—nephrolithiasis	0.000417	0.00428	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.000413	0.00424	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SLC26A1—nephrolithiasis	0.000374	0.00384	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—AGXT—nephrolithiasis	0.000368	0.00378	CbGpPWpGaD
Fluorescein—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.000333	0.00342	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.000313	0.00322	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—APRT—nephrolithiasis	0.000313	0.00322	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—AQP1—nephrolithiasis	0.000297	0.00305	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CHRM3—nephrolithiasis	0.000269	0.00276	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GRHPR—nephrolithiasis	0.000246	0.00253	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—AQP1—nephrolithiasis	0.000223	0.00229	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AGXT—nephrolithiasis	0.000219	0.00225	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CHRM3—nephrolithiasis	0.000202	0.00207	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SLC26A1—nephrolithiasis	0.000187	0.00192	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—APRT—nephrolithiasis	0.000187	0.00192	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—AQP1—nephrolithiasis	0.000133	0.00136	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CHRM3—nephrolithiasis	0.00012	0.00123	CbGpPWpGaD
